The impact of HIV infection on primary headache. Unexpected findings from retrospective, cross-sectional, and prospective analyses

Pain

Volumn 85, Issue 1-2, 2000, Pages 191-200

  Evers, Stefan ^a   Wibbeke, Barbara ^a   Reichelt, Doris ^a   Suhr, Birgit ^a   Brilla, Roland ^a   Husstedt, Ingo W ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

AIDS; HIV infection; Migraine; Symptomatic headache; Tension type headache

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TENSION HEADACHE; VIRUS INFECTION;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEADACHE DISORDERS; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIGRAINE DISORDERS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TENSION-TYPE HEADACHE;

EID: 0033952150     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00266-3     Document Type: Article

References (35)

1. Baily G.G., Mandal B.K. Recurrent transient neurological deficits in advanced HIV infection. AIDS. 9:1995;709-712.
2. Berger J.R., Stein N., Pall L. Headache and human immunodeficiency virus infection: a case control study. Eur Neurol. 36:1996;229-233.
3. Blanchard B.M. Cluster headache associated with parainfluenza virus, preceded and succeeded by migraine. Headache. 38:1998;132-134.
4. Brew B.J., Miller J. Human immunodeficiency virus-related headache. Neurology. 43:1993;1098-1100.
5. Brew B.J., Miller J. Human immunodeficiency virus type 1-related transient neurological deficits. Am J Med. 101:1996;257-261.
6. Brilla R., Evers S., Sörös P., Husstedt I.W. Hemicrania continua in an HIV-infected outpatient. Cephalalgia. 18:1998;287-288.
7. Brilla R., Evers S., Nabavi D.G., Schulte-Altedorneburg G., Kemeny V., Reichelt D., Husstedt I.W. Cerebral vasculopathy in HIV infection revealed by transcranial Doppler. Stroke. 30:1999;811-813.
8. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR. 41:1992;1-19.
9. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. Neurology. 47:1996;1247-1253.
10. Evers S., Grotemeyer K.H., Reichelt D., Lüttmann S., Husstedt I.W. Impact of antiretroviral treatment on AIDS dementia: a longitudinal prospective event-related potential study. J Acquired Immune Defic Syndr. 17:1998;143-148.
11. Evers S., Brilla R., Husstedt I.W. Headache and human immunodeficiency virus infection - a systematic review. Headache Q. 9:1998;129-133.
12. Forseter G., Joline C., Wormser G.P. Tolerability, safety, and acceptability of zidovudine prophylaxis in health care workers. Arch Intern Med. 154:1994;2745-2749.
13. Friedmann P.D., Samore M.H., Kraemer K.L., Calkins D.R. Clinical correlates of secondary meningitis in HIV-infected adults. Arch Intern Med. 155:1995;2231-2237.
14. Göbel H., Petersen-Braun M., Soyka D. The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia. 14:1994;97-106.
15. Goldstein J. Headache and acquired immunodeficiency syndrome. Neurol Clin. 8:1990;947-960.
16. Gray F., Scaravilli F., Everall I., Chretien F., An S., Boche D., Adle-Biassette H., Wingertsmann L., Durigon M., Hurtrel B., Chiodi F., Bell J., Lantos P. Neuropathology of early HIV-1 infection. Brain Pathol. 6:1996;1-15.
17. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 8:(suppl 7):1988;1-93.
18. Hewitt D.J., McDonald M., Portenoy R.K., Rosenfeld B., Passik S., Breitbart W. Pain syndromes and etiologies in ambulatory AIDS patients. Pain. 70:1997;117-123.
19. Holloway R.G., Kieburtz K.D. Headache and the human immunodeficiency virus type 1 infection. Headache. 35:1995;245-255.
20. Lipton R.B., Feraru E.R., Weiss G., Chhabria M., Harris C., Aronow H., Newman L.C., Solomon S. Headache in HIV-1-related disorders. Headache. 31:1991;518-522.
21. Lipton R.B., Stewart W.F. Prevalence and impact of migraine. Neurol Clin. 15:1997;1-13.
22. Martelletti P., di Sabato F., Mezzaroma I., Aiuti F., Giacovazzo M. Cluster headache in a HIV-infected individual: a case report. Immunol Clin. 12:1993;205-208.
23. Mathew N., Saper J.R., Silberstein S.D., Rankin L., Markley H.G., Solomon S., Rapoport A.M., Silber C.J., Deaton R.L. Migraine prophylaxis with divalproex. Arch Neurol. 52:1995;281-286.
24. Mirsattari S.M., Power C., Nath A. Primary headaches in HIV-infected patients. Headache. 39:1999;3-10.
25. O'Neill W.M., Sherrard J.S. Pain in human immunodeficiency virus disease: a review. Pain. 54:1993;3-14.
26. Penfold J., Clark A.J.M. Pain syndromes in HIV infection. Can J Anaesth. 39:1992;724-730.
27. Qureshi A.I., Janssen R.S., Karon J.M., Weissman J.P., Akbar M.S., Safdar K., Frankel M.R. Human immunodeficiency virus infection and stroke in young patients. Arch Neurol. 54:1997;1150-1153.
28. Rachlis A., Fanning M.M. Zidovudine toxicity. Clinical features and management. Drug Saf. 8:1993;312-320.
29. Rasmussen B.K. Epidemiology of headache. Cephalalgia. 15:1995;45-68.
30. Rinaldi R., Manfredi R., Azzimodi G., Rodorigo G., Tonon C., De Rosa V., Mastroianni A., Coronado O.V., Legnani C., Chiodo F., D'Alessandro R. Recurrent 'migrainelike' episodes in patients with HIV disease. Headache. 37:1997;443-448.
31. Singer E.J., Zorilla C., Fahy-Chandon B., Chi S., Syndulko K., Tourtelotte W.W. Painful symptoms reported by ambulatory HIV-infected men in a longitudinal study. Pain. 54:1993;15-19.
32. Singer E.J., Kim J., Fahy-Chandin B., Datt A., Tourtellotte W.W. Headache in ambulatory HIV-1-infected men enrolled in a longitudinal study. Neurology. 46:1996;487-494.
33. Sjaastad O., Spierings E.L. 'Hemicrania continua': another headache absolutely responsive to indomethacin. Cephalalgia. 4:1984;65-70.
34. Van Paesschen W., Bodian C., Maker H. Metabolic abnormalities and new-onset seizures in human immunodeficiency virus-positive patients. Epilepsia. 36:1995;146-150.
35. Wittrock D.A., Ficek S.K., Cook T.M. Headache-free controls? Evidence of headache in individuals who deny having headaches during diagnostic screening. Headache. 36:1996;416-418.